Therapy for Kaposi's sarcoma : Recent advances and experimental approachesYARCHOAN, R.Journal of acquired immune deficiency syndromes and human retrovirology. 1999, Vol 21, pp s66-s73, issn 1077-9450, SUP1Conference Paper

HUMAN T-CELL SUBSET REQUIREMENTS FOR THE PRODUCTION OF SPECIFIC ANTI-INFLUENZAVIRUS ANTIBODY IN VITROYARCHOAN R; BIDDISON WE; SCHNEIDER HS et al.1982; J. CLIN. IMMUNOL.; ISSN 503894; USA; DA. 1982; VOL. 2; NO 9; PP. 118-125; BIBL. 37 REF.Article

SIMULTANEOUS INDUCTION OF ANTIGEN-SPECIFIC IGA HELPER T CELLS AND IGG SUPPRESSOR T CELLS IN THE MURINE PEYER'S PATCH AFTER PROTEIN FEEDINGRICHMAN LK; GRAEFF AS; YARCHOAN R et al.1981; J. IMMUNOL.; ISSN 0022-1767; USA; DA. 1981; VOL. 126; NO 6; PP. 2079-2083; BIBL. 26 REF.Article

Anti-retroviral therapy of AIDS and related disorders: general principles and specific development of dideoxynucleosidesYARCHOAN, R; BRODER, S.Pharmacology & therapeutics (Oxford). 1989, Vol 40, Num 3, pp 329-348, issn 0163-7258Article

PSYCHIATRIC ASPECTS OF ALLOGENEIC BONE MARROW TRANSPLANTATION FOR APLASTIC ANEMIA.POPKIN MK; MOLDOW CF; HALL RCW et al.1977; DIS. NERV. SYST.; U.S.A.; DA. 1977; VOL. 38; NO 11; PP. 925-927; BIBL. 9 REF.Article

SPECIFIC ANTI-INFLUENZA VIRUS ANTIBODY PRODUCTION IN VITRO BY LYMPHOCYTES FROM A SUBSET OF PATIENTS WITH HYPOGAMMAGLOBULINEMIAYARCHOAN R; SCHNEIDER HS; WRAY BB et al.1983; JOURNAL OF CLINICAL INVESTIGATION; ISSN 0021-9738; USA; DA. 1983; VOL. 71; NO 6; PP. 1720-1727; BIBL. 29 REF.Article

IN VITRO PRODUCTION OF ANTI-INFLUENZA VIRUS ANTIBODY AFTER INTRANASAL INOCULATION WITH COLD-ADAPTED INFLUENZA VIRUSYARCHOAN R; MURPHY BR; STROBER W et al.1981; J. IMMUNOL.; ISSN 0022-1767; USA; DA. 1981; VOL. 127; NO 5; PP. 1958-1963; BIBL. 37 REF.Article

Dideoxycytidine : current clinical experience and future prospects : a summaryBRODER, S; YARCHOAN, R.The American journal of medicine. 1990, Vol 88, pp 5B.31S-5B.33S, issn 0002-9343, Suppl. 5BConference Paper

Specificity of in vitro anti-influenza virus antibody production by human lymphocytes: analysis of original antigenic sin by limiting dilution culturesYARCHOAN, R; NELSON, D. L.The Journal of immunology (1950). 1984, Vol 132, Num 2, pp 928-935, issn 0022-1767Article

LIMITING DILUTION ANALYSIS OF EPSTEIN-BARR VIRUS-INDUCED IMMUNOGLOBULIN PRODUCTION BY HUMAN B CELLSYARCHOAN R; TOSATO G; BLAESE RM et al.1983; J. EXP. MED.; ISSN 0022-1007; USA; DA. 1983; VOL. 157; NO 1; PP. 1-14; BIBL. 2 P.Article

CRYPTOCOCCAL MENINGITIS WITH FALSE-POSITIVE CYTOLOGY IN THE CSF: USE OF T-CELL ROSETTING TO EXCLUDE MENINGEAL LYMPHOMADAVIES SF; GORMUS BJ; YARCHOAN R et al.1978; J.A.M.A.; USA; DA. 1978; VOL. 239; NO 22; PP. 2369-2370; BIBL. 6 REF.Article

Correlations between the in vitro and in vivo activity of anti-HIV agents : implications for future drug developmentYARCHOAN, R; BRODER, S.Journal of enzyme inhibition. 1992, Vol 6, Num 1, pp 99-111, issn 8755-5093Article

SPECIFIC ANTI-INFLUENZA VIRUS ANTIBODY PRODUCTION IN VITRO BY HUMAN PERIPHERAL BLOOD MONONUCLEAR CELLS = PRODUCTION IN VITRO PAR DES CELLULES MONONUCLEAIRES DU SANG PERIPHERIQUE HUMAIN D'ANTICORPS SPECIFIQUES ANTI-INFLUENZAVIRUSYARCHOAN R; MURPHY BR; STROBER W et al.1981; J. IMMUNOL.; ISSN 0022-1767; USA; DA. 1981; VOL. 127; NO 6; PP. 2588-2594; BIBL. 32 REF.Article

ISOLATED CANDIDA PARAPSILOSIS ARTHRITIS IN A HEROIN ADDICTYARCHOAN R; DAVIES SF; FRIED J et al.1979; J. RHEUMATOL.; CAN; DA. 1979; VOL. 6; NO 4; PP. 447-450; BIBL. 17 REF.Article

HEMAGGLUTININ-SPECIFIC ENZYME-LINKED IMMUNOSORBENT ASSAY FOR ANTIBODIES TO INFLUENZA A AND B VIRUSESMURPHY BR; PHELAN MA; NELSON DL et al.1981; J. CLIN. MICROBIOL.; ISSN 0095-1137; USA; DA. 1981; VOL. 13; NO 3; PP. 554-560; BIBL. 28 REF.Article

Clinical and basic advances in the antiretroviral therapy of human immunodeficiency virus infectionYARCHOAN, R; MITSUYA, H; BRODER, S et al.The American journal of medicine. 1989, Vol 87, pp 191-200, issn 0002-9343Article

Relationship between immunoglobulin production and immortalization Epstein Barr virusTOSATO, G; BLAESE, R. M; YARCHOAN, R et al.The Journal of immunology (1950). 1985, Vol 135, Num 2, pp 959-964, issn 0022-1767Article

Challenges in the therapy of HIV infectionYARCHOAN, R; MITSUYA, H; BRODER, S et al.Immunology today (Amsterdam. Regular ed.). 1993, Vol 14, Num 6, pp 303-309, issn 0167-5699Article

Hematologic effects of AIDS therapiesPLUDA, J. M; MITSUYA, H; YARCHOAN, R et al.Hematology/oncology clinics of North America. 1991, Vol 5, Num 2, pp 229-248, issn 0889-8588, 20 p.Article

Molecular targets for AIDS therapyMITSUYA, H; YARCHOAN, R; BRODER, S et al.Science (Washington, D.C.). 1990, Vol 249, Num 4976, pp 1533-1544, issn 0036-8075, 12 p.Article

Therapy of AIDS and AIDS-associated neoplasmsPLUDA, J. M; BRODER, S; YARCHOAN, R et al.Cancer chemotherapy and biological response modifiers annual. 1992, Vol 13, pp 404-439, issn 0921-4410Article

Therapy of AIDS and AIDS-related tumorsPLUDA, J. M; BRODER, S; YARCHOAN, R et al.Cancer chemotherapy and biological response modifiers annual. 1991, Vol 12, pp 395-429, issn 0921-4410, 35 p.Article

Targeted therapy of human immunodeficiency virus-related diseaseMITSUYA, H; YARCHOAN, R; KAGEYAMA, S et al.The FASEB journal. 1991, Vol 5, Num 10, pp 2369-2381, issn 0892-6638Article

Antiviral therapy against HIV infectionMITSUYA, H; YARCHOAN, R; HAYASHI, S et al.Journal of the American Academy of Dermatology. 1990, Vol 22, Num 6, pp 1282-1294, issn 0190-9622, 2Article

Mechanisms of B cell activation in patients with acquired immunodeficiency syndrome and related disorders: contribution of antibody-producing B cells, of Epstein-Barr virus-infected B cells, and of immunoglobulin production induced by human T cell lymphotropic virus, type III/lymphadenopathy-associated virusYARCHOAN, R; REDFIELD, R. R; BRODER, S et al.The Journal of clinical investigation. 1986, Vol 78, Num 2, pp 439-447, issn 0021-9738Article